Back

Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

29 August 2020 (09:37 - 09:46)
Organised by:
Congress Presentation Part of: Translating Basic Science Discoveries into Clinical Practice Basic Science, Other ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Noriaki Yamada

Osaka University Graduate School of Medicine, Suita (Japan)

3 More presentations in this session

Presentation thumbnail
Dietary spermidine: a story of cardioprotection and longevity.
Doctor M. Abdellatif (Graz, AT)
Slides Video
Presentation thumbnail
A novel anti-arrhythmic drug: the TASK-1 channel tale.
Professor C. Schmidt (Goettingen, DE)
Slides Video
Presentation thumbnail
Activation of invariant natural killer T cells for heart failure therapy.
Doctor M. Ikeda (Fukuoka, JP)
Slides Video

Access the full session

Session thumbnail
Translating Basic Science Discoveries into Clinical Practice

The Event

Event poster

ESC Congress 2020

29 August 2020 09:37 CET
You may be interested in
thumbnail
Congress Presentation
Unravelling the signaling pathway downstream of the neurokinin receptor in atrium: discovering novel anti-arrhythmic targets for treatment of atrial fibrillation
28 August 2023
thumbnail
Congress Session
Ventricular arrhythmias and prevention of sudden cardiac death (4)
31 March 2025
thumbnail
Congress Presentation
The KCNN3 rs13376333 risk variant reduces the SK-current density in isogenic stem cell-derived and native human atrial myocytes
29 August 2025
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources